|
Volumn 280, Issue 7486, 2008, Pages 86-87
|
Access to experimental drugs: Legal and ethical issues of paternalism
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
NEW DRUG;
ONCOLYTIC SENECA VALLEY VIRUS;
ONCOLYTIC VIRUS;
ROFECOXIB;
SVV 001;
TGN 1412;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
BRAIN CANCER;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG COST;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG SAFETY;
DRUG WITHDRAWAL;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HUMAN;
INFORMED CONSENT;
LEGAL ASPECT;
LEGAL LIABILITY;
LICENSING;
MEDICAL DECISION MAKING;
MEDICAL ETHICS;
ONCOLYTIC VIROTHERAPY;
PATERNALISM;
PATIENT AUTONOMY;
PATIENT DECISION MAKING;
PATIENT RIGHT;
PHARMACEUTICAL CARE;
POSTMARKETING SURVEILLANCE;
RISK BENEFIT ANALYSIS;
SELF MEDICATION;
|
EID: 38949084879
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (8)
|